EXAS - EXACT SCIENCES CORP

103.5
0.130   0.126%

Share volume: 2,285,427
Last Updated: 03-04-2026
Healthcare/Services – Health: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$103.37
0.13
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 0%
Dept financing 27%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.01%
1 Month
1.08%
3 Months
2.21%
6 Months
101.07%
1 Year
111.91%
2 Year
74.61%
Key data
Stock price
$103.50
P/E Ratio 
0.00
DAY RANGE
$103.25 - $103.54
EPS 
-$1.10
52 WEEK RANGE
$38.81 - $103.67
52 WEEK CHANGE
$117.03
MARKET CAP 
19.243 B
YIELD 
N/A
SHARES OUTSTANDING 
190.888 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,188,900
AVERAGE 30 VOLUME 
$2,257,051
Company detail
CEO: Kevin T. Conroy
Region: US
Website: exactsciences.com
Employees: 6,400
IPO year: 2001
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Exact Sciences Corporation provides cancer screening and diagnostic test products. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers.

Recent news